Cellu Tissue Holdings, Inc. - FORM 10-K - EX-32.2 - SECTION 906 CFO CERTIFICATION - April 30, 2010

Attached files

file filename
10-K - FORM 10-K - Cellu Tissue Holdings, Inc.d10k.htm
EX-23.2 - CONSENT OF ERNST & YOUNG LLP - Cellu Tissue Holdings, Inc.dex232.htm
EX-21.1 - LIST OF SUBSIDIARIES OF THE COMPANY - Cellu Tissue Holdings, Inc.dex211.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Cellu Tissue Holdings, Inc.dex311.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - Cellu Tissue Holdings, Inc.dex231.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - Cellu Tissue Holdings, Inc.dex321.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Cellu Tissue Holdings, Inc.dex312.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in connection with the Annual Report on Form 10-K of Cellu Tissue Holdings, Inc. (the “Company”) for the year ended February 28, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, the Senior Vice President, Finance and Chief Financial Officer of the Company, certifies that:

 

  1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrants.

 

/S/ DAVID J. MORRIS

David J. Morris

Senior Vice President, Finance and

Chief Financial Officer

April 30, 2010

Cellu Tissue Holdings, Inc. Reports